Insmed Incorporated (BMV:INSM)

Insmed Statistics

Total Valuation

Insmed has a market cap or net worth of MXN 522.39 billion. The enterprise value is 501.49 billion.

Market Cap	522.39B
Enterprise Value	501.49B

Important Dates

The next estimated earnings date is Thursday, October 30, 2025.

Earnings Date	Oct 30, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	211.37M
Shares Outstanding	n/a
Shares Change (YoY)	+22.38%
Shares Change (QoQ)	+4.67%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	190.46M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	69.58
PB Ratio	22.17
P/TBV Ratio	25.58
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-25.71
EV / Sales	67.37
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-30.62

Financial Position

The company has a current ratio of 6.68, with a Debt / Equity ratio of 0.59.

Current Ratio	6.68
Quick Ratio	6.13
Debt / Equity	0.59
Debt / EBITDA	n/a
Debt / FCF	-0.85
Interest Coverage	-10.49

Financial Efficiency

Return on equity (ROE) is -160.54% and return on invested capital (ROIC) is -34.07%.

Return on Equity (ROE)	-160.54%
Return on Assets (ROA)	-27.03%
Return on Invested Capital (ROIC)	-34.07%
Return on Capital Employed (ROCE)	-42.79%
Revenue Per Employee	5.91M
Profits Per Employee	-15.35M
Employee Count	1,271
Asset Turnover	0.19
Inventory Turnover	0.98

Taxes

In the past 12 months, Insmed has paid 83.64 million in taxes.

Income Tax	83.64M
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	n/a
Average Volume (20 Days)	1,200

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.71

Income Statement

In the last 12 months, Insmed had revenue of MXN 7.51 billion and -19.51 billion in losses. Loss per share was -107.88.

Revenue	7.51B
Gross Profit	5.68B
Operating Income	-17.49B
Pretax Income	-19.42B
Net Income	-19.51B
EBITDA	-17.30B
EBIT	-17.49B
Loss Per Share	-107.88

Balance Sheet

The company has 35.02 billion in cash and 13.94 billion in debt, giving a net cash position of 21.08 billion.

Cash & Cash Equivalents	35.02B
Total Debt	13.94B
Net Cash	21.08B
Net Cash Per Share	n/a
Equity (Book Value)	23.57B
Book Value Per Share	111.64
Working Capital	33.38B

Cash Flow

In the last 12 months, operating cash flow was -15.93 billion and capital expenditures -452.88 million, giving a free cash flow of -16.38 billion.

Operating Cash Flow	-15.93B
Capital Expenditures	-452.88M
Free Cash Flow	-16.38B
FCF Per Share	n/a

Margins

Gross margin is 75.72%, with operating and profit margins of -233.02% and -259.82%.

Gross Margin	75.72%
Operating Margin	-233.02%
Pretax Margin	-258.70%
Profit Margin	-259.82%
EBITDA Margin	-230.46%
EBIT Margin	-233.02%
FCF Margin	n/a

Dividends & Yields

Insmed does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-22.38%
Shareholder Yield	n/a
Earnings Yield	-3.73%
FCF Yield	-3.14%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Insmed has an Altman Z-Score of 3.44 and a Piotroski F-Score of 3.

Altman Z-Score	3.44
Piotroski F-Score	3